These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26609882)

  • 21. 5-hydroxytryptamine medications for the treatment of obesity.
    Burke LK; Heisler LK
    J Neuroendocrinol; 2015 Jun; 27(6):389-98. PubMed ID: 25925636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence.
    Bubar MJ; Cunningham KA
    Curr Top Med Chem; 2006; 6(18):1971-85. PubMed ID: 17017968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes.
    Löfdahl A; Wenglén C; Rydell-Törmänen K; Westergren-Thorsson G; Larsson-Callerfelt AK
    Am J Pathol; 2018 May; 188(5):1113-1119. PubMed ID: 29454752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Horse chestnut extract contracts bovine vessels and affects human platelet aggregation through 5-HT(2A) receptors: an in vitro study.
    Felixsson E; Persson IA; Eriksson AC; Persson K
    Phytother Res; 2010 Sep; 24(9):1297-301. PubMed ID: 20148408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kisspeptin1 modulates odorant-evoked fear response via two serotonin receptor subtypes (5-HT1A and 5-HT2) in zebrafish.
    Nathan FM; Ogawa S; Parhar IS
    J Neurochem; 2015 Jun; 133(6):870-8. PubMed ID: 25818845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
    Nair SG; Gudelsky GA
    Synapse; 2004 Sep; 53(4):202-7. PubMed ID: 15266551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
    Rosenzweig-Lipson S; Comery TA; Marquis KL; Gross J; Dunlop J
    Handb Exp Pharmacol; 2012; (213):147-65. PubMed ID: 23027415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do classical hallucinogens act as 5-HT2 agonists or antagonists?
    Glennon RA
    Neuropsychopharmacology; 1990; 3(5-6):509-17. PubMed ID: 2078284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
    Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
    Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin induces melanogenesis via serotonin receptor 2A.
    Lee HJ; Park MK; Kim SY; Park Choo HY; Lee AY; Lee CH
    Br J Dermatol; 2011 Dec; 165(6):1344-8. PubMed ID: 21711335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crucial Roles of 5-HT and 5-HT2 Receptor in Diabetes-Related Lipid Accumulation and Pro-Inflammatory Cytokine Generation in Hepatocytes.
    Fu J; Li C; Zhang G; Tong X; Zhang H; Ding J; Ma Y; Cheng R; Hou S; An S; Li X; Ma S
    Cell Physiol Biochem; 2018; 48(6):2409-2428. PubMed ID: 30121645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).
    Leopoldo M; Lacivita E; Berardi F; Perrone R
    Expert Opin Ther Pat; 2010 Jun; 20(6):739-54. PubMed ID: 20476847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.
    Ivachtchenko AV; Ivanenkov YA; Skorenko AV
    Expert Opin Ther Pat; 2012 Oct; 22(10):1123-68. PubMed ID: 22957857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of acid-sensing ion channel activity by the activation of 5-HT₂ receptors in rat dorsal root ganglion neurons.
    Qiu F; Qiu CY; Liu YQ; Wu D; Li JD; Hu WP
    Neuropharmacology; 2012 Sep; 63(3):494-500. PubMed ID: 22580376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming Depression with 5-HT
    Zięba A; Stępnicki P; Matosiuk D; Kaczor AA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 5-HT(2C) mediated mechanisms involved in urethral sphincter reflexes in a guinea-pig model of urethral function.
    Conlon K; Miner W; McCleary S; McMurray G
    BJU Int; 2012 Jul; 110(2 Pt 2):E113-7. PubMed ID: 22192599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    Zeeb FD; Higgins GA; Fletcher PJ
    ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT receptor subtypes as key targets in mediating pigment dispersion within melanophores of teleost, Oreochromis mossambicus.
    Salim S; Ali AS; Ali SA
    Comp Biochem Physiol B Biochem Mol Biol; 2013 Feb; 164(2):117-23. PubMed ID: 23195131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia.
    Yao JK; Magan S; Sonel AF; Gurklis JA; Sanders R; Reddy RD
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):171-6. PubMed ID: 15253886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice.
    Mori T; Komiya S; Ohya J; Uzawa N; Sugiyama K; Saitoh Y; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2014 Oct; 740():160-7. PubMed ID: 25034809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.